Q1 2024 · 13F-HR/A
Birchview Capital, LPholdings as filed
Filed 2025-06-30 · accession 0001618205-25-000005
$122.7M
Reported value
59
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $38.2M | 31.1% | 703,606 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $10.7M | 8.68% | 77,240 | Common | SOLE |
| 09075X108 | — | BIODESIX INC COM RST | $7.6M | 6.22% | 5,348,273 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $5.2M | 4.25% | 1,655,184 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $4.6M | 3.77% | 250,400 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $4.4M | 3.56% | 84,200 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $4.2M | 3.42% | 169,574 | Common | SOLE |
| 74838J101 | — | QUIDELORTHO CORP | $3.1M | 2.55% | 65,203 | Common | SOLE |
| 82710M100 | SILKUSD | SILK ROAD MEDICAL INC | $2.9M | 2.36% | 158,094 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.8M | 2.31% | 210,000 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $2.7M | 2.24% | 114,700 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $2.5M | 2.06% | 11,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $2.2M | 1.83% | 15,280 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $2.2M | 1.76% | 320,930 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $2.0M | 1.62% | 150,000 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $1.9M | 1.51% | 460,000 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $1.7M | 1.38% | 48,448 | Common | SOLE |
| 294600101 | ETRNUSD | EQUITRANS MIDSTREAM CORPORATIO | $1.7M | 1.35% | 133,050 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $1.4M | 1.14% | 173,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.4M | 1.13% | 48,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 1.10% | 50,000 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $1.3M | 1.03% | 50,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $1.2M | 0.99% | 88,000 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $1.1M | 0.92% | 30,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.1M | 0.86% | 18,000 | Common | SOLE |
| 723787107 | PXDEUR | PIONEER NATURAL RESOURCES CO | $997,500 | 0.81% | 3,800 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $940,620 | 0.77% | 122,000 | Common | SOLE |
| 74340E103 | PGNY | PROGYNY INC | $839,300 | 0.68% | 22,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $709,446 | 0.58% | 469,832 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $701,100 | 0.57% | 10,000 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $645,300 | 0.53% | 270,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $619,200 | 0.50% | 15,000 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $591,900 | 0.48% | 30,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $545,560 | 0.44% | 46,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $492,200 | 0.40% | 10,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $463,400 | 0.38% | 7,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $430,500 | 0.35% | 10,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $427,943 | 0.35% | 25,114 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $411,136 | 0.34% | 321,200 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $406,800 | 0.33% | 10,000 | Common | SOLE |
| G11196105 | — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $402,792 | 0.33% | 7,365 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $345,600 | 0.28% | 80,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $329,840 | 0.27% | 28,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $323,650 | 0.26% | 2,500 | Common | SOLE |
| 00430H102 | — | ACCELERATE DIAGNOSTICS INC | $321,986 | 0.26% | 325,239 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $319,200 | 0.26% | 4,000 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $310,100 | 0.25% | 14,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $272,199 | 0.22% | 12,300 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $252,160 | 0.21% | 16,000 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $246,800 | 0.20% | 40,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $170,600 | 0.14% | 10,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $163,048 | 0.13% | 138,176 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $158,400 | 0.13% | 28,800 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $147,500 | 0.12% | 10,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $106,107 | 0.09% | 19,833 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $101,600 | 0.08% | 20,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $77,000 | 0.06% | 50,000 | Common | SOLE |
| 71902K105 | — | CERO THERAPEUTICS HOLDINGS INC | $39,824 | 0.03% | 12,972 | Common | SOLE |
| 98585K102 | — | YIELD10 BIOSCIENCE INC | $7,125 | 0.01% | 18,750 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.